Drug class in one race
HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease
5 tracked HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
1 approved / phase 42 Phase 31 Phase 21 preclinical / unstaged
Head-to-head evidence: Atovastatin vs Monorova · Atovastatin vs Rosuvastatin · Atovastatin vs UIC201604 · Atovastatin vs Zhibitai · Monorova vs Rosuvastatin · Monorova vs UIC201604